Загрузка видео...

Не удалось загрузить видео

На главную

Catch up on 𝘏𝘌𝘙2-mutant non-small cell lung cancer (NSCLC) data presented at ASCO 2026 Dr Herbert Loong, MBBS, FASCO & Dr Isabel Preeshagul joined us at ASCO 2026 to share their views on data emerging from the meeting 📺 Watch the video to get their expert insights on data...

lung_connect's profile picture

LUNG CONNECT powered by COR2ED

1,021 subscribers

841,885 просмотров • 1 месяц назад •via X (Twitter)

Наука и технологииОбразованиеЗдоровье и велнес
LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

Lung cancer e-learning for HCPs Topic: the evolving TROP2-directed ADC landscape in metastatic NSCLC + strategies to optimise the treatment experience Endorsed by ICAN, International Cancer Advocacy Network, Exon 20 Group, a multistakeholder organization & Biomarker Collaborative Supported by an Independent Educational Grant from AstraZeneca 📹
1:15

Lung cancer e-learning for HCPs Topic: the evolving TROP2-directed ADC landscape in metastatic NSCLC + strategies to optimise the treatment experience Endorsed by ICAN, International Cancer Advocacy Network, Exon 20 Group, a multistakeholder organization & Biomarker Collaborative Supported by an Independent Educational Grant from AstraZeneca 📹

LUNG CONNECT powered by COR2ED

4,994,160 просмотров • 1 месяц назад

Breast Cancer highlights from ASCO 2026! Dr Paolo Tarantino joined us at ASCO to share his expert insights on key trial data from ASCENT-03, ASCENT-04, TROPION-Breast02, SERENA-6, VIKTORIA-1, & OPTIMA How will these data impact clinical practice? 📺 Watch his update to find out! >> Programme endorsed by ICAN, International Cancer Advocacy Network This educational programme is supported by COR2ED
3:06

Breast Cancer highlights from ASCO 2026! Dr Paolo Tarantino joined us at ASCO to share his expert insights on key trial data from ASCENT-03, ASCENT-04, TROPION-Breast02, SERENA-6, VIKTORIA-1, & OPTIMA How will these data impact clinical practice? 📺 Watch his update to find out! >> Programme endorsed by ICAN, International Cancer Advocacy Network This educational programme is supported by COR2ED

COR2ED

2,492,246 просмотров • 2 месяцев назад

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
1:07

Survey results published: Patient understanding of biomarker testing in non-small cell lung cancer (NSCLC) We surveyed patients & caregivers to assess awareness, knowledge & attitudes surrounding biomarker testing in NSCLC 📹 The results highlight gaps we can address to better support shared decision-making From medical experts Prof. Christian Rolfo , Prof. Fernando López-Ríos & Dr Rodrigo Paredes, MD , and made in collaboration with patient advocacy experts Dr. Amy C. Moore, Dr Anne-Marie Baird & Shani Shilo This programme is endorsed by LUNGevity Foundation, The Israeli Lung Cancer Foundation, NTRKers & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

LUNG CONNECT powered by COR2ED

2,703,909 просмотров • 1 месяц назад

Are ADCs the next therapeutic options for pts w/ pretreated HR+/HER2- (IHC 0) metastatic breast cancer who have developed an endocrine resistance? Find out as you follow a pt journey in this case-based video Endorsed by ICAN, International Cancer Advocacy Network Biomarker Collaborative GRASP & Exon 20 Group, a multistakeholder organization Supported by an Independent Educational Grant from AstraZeneca.
9:15

Are ADCs the next therapeutic options for pts w/ pretreated HR+/HER2- (IHC 0) metastatic breast cancer who have developed an endocrine resistance? Find out as you follow a pt journey in this case-based video Endorsed by ICAN, International Cancer Advocacy Network Biomarker Collaborative GRASP & Exon 20 Group, a multistakeholder organization Supported by an Independent Educational Grant from AstraZeneca.

BREAST CANCER CONNECT

1,019,784 просмотров • 11 месяцев назад

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer
4:51

Personalised treatment in childhood cancer: A journey through 𝘕𝘛𝘙𝘒 fusion testing 📺Video for patients & families – please share with your network From Linet Menachery, patient advocate and mother of a child diagnosed with an 𝘕𝘛𝘙𝘒 fusion-positive pediatric cancer Endorsed by NTRKers, ICAN, International Cancer Advocacy Network & Biomarker Collaborative Supported by an Independent Educational Grant from Bayer

COR2ED

5,214,734 просмотров • 5 месяцев назад

🚨Update from #ESMO24 Upper GI cancer data 🚨 Dr Lizzy Smyth & Dr Sam Klempner joined us at ESMO to share their insights into new #UpperGI cancer data & the potential impact on clinical practice. 📺 Watch their video update Supported by Bayer #MedEd #oncology #OncTwitter
2:35

🚨Update from #ESMO24 Upper GI cancer data 🚨 Dr Lizzy Smyth & Dr Sam Klempner joined us at ESMO to share their insights into new #UpperGI cancer data & the potential impact on clinical practice. 📺 Watch their video update Supported by Bayer #MedEd #oncology #OncTwitter

GI CONNECT powered by COR2ED

160,747 просмотров • 1 год назад

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED
5:30

Update from ESMO 2025! >> Endometrial & ovarian cancer highlights 📺 Prof. Nicoletta Colombo reviews the latest data in gynecological cancers presented at the congress Could these developments impact clinical practice? Watch to find out! Endorsed by ICAN, International Cancer Advocacy Network This independent programme is supported by COR2ED

COR2ED

114,711 просмотров • 10 месяцев назад

Managing ADC toxicities in HER2+ metastatic breast cancer - spotlight on nausea & vomiting Nausea/vomiting are common AEs associated with ADCs, particularly T-DXd, along with fatigue ILD, while less common, is an AE of special interest How can you manage N/V and more in clinical practice? Get step-by-step guidance from Dr Sara Tolaney Endorsed by ICAN, International Cancer Advocacy Network Supported by an Independent Educational Grant from AstraZeneca
6:39

Managing ADC toxicities in HER2+ metastatic breast cancer - spotlight on nausea & vomiting Nausea/vomiting are common AEs associated with ADCs, particularly T-DXd, along with fatigue ILD, while less common, is an AE of special interest How can you manage N/V and more in clinical practice? Get step-by-step guidance from Dr Sara Tolaney Endorsed by ICAN, International Cancer Advocacy Network Supported by an Independent Educational Grant from AstraZeneca

BREAST CANCER CONNECT powered by COR2ED

528,125 просмотров • 10 месяцев назад

ADCs in HER2+ metastatic breast cancer: management of adverse events Get step-by-step strategies to support effective management of T-DXd–related adverse events in HER2+ mBC > N/V > Fatigue > Interstitial lung disease (rare but critical) From Prof. Shaheenah Dawood, Dr Sara Tolaney, Prof. Javier Cortes MD PhD, Carla Whitbread, Dr Grazyna Suchodolska & Prof. Giuseppe Curigliano Endorsed by the European Oncology Nursing Society (@cancernurseEU) and Europa Donna Supported by an Independent Educational Grant from AstraZeneca
3:41

ADCs in HER2+ metastatic breast cancer: management of adverse events Get step-by-step strategies to support effective management of T-DXd–related adverse events in HER2+ mBC > N/V > Fatigue > Interstitial lung disease (rare but critical) From Prof. Shaheenah Dawood, Dr Sara Tolaney, Prof. Javier Cortes MD PhD, Carla Whitbread, Dr Grazyna Suchodolska & Prof. Giuseppe Curigliano Endorsed by the European Oncology Nursing Society (@cancernurseEU) and Europa Donna Supported by an Independent Educational Grant from AstraZeneca

BREAST CANCER CONNECT powered by COR2ED

7,264,152 просмотров • 5 месяцев назад

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA
4:31

GI CONNECT podcast episode Tackling metastatic pancreatic ductal adenocarcinoma (mPDAC) Dr. Shubham Pant & Prof. Efrat Dotan MD discuss chemotherapy strategies that matter Conversation topics include: - Efficacy & safety profiles - Relevance of mode of delivery - Cause of toxicities - Strategies to manage side effects 📹 Highlights video in this post Endorsed by ICAN, International Cancer Advocacy Network Digestive Cancers Europe The National Pancreas Foundation PanCAN Supported by an Independent Educational Grant from Ipsen USA

GI CONNECT powered by COR2ED

1,202,878 просмотров • 10 месяцев назад

COVID vaccines linked to a 27% INCREASE in overall cancer risk, South Korean study finds. “There’s a one in a thousand chance that this result arose by chance,” Dr. John Campbell noted. Children’s Health Defense reports: The study used data from 2021-2023 for over 8.4 million people in South Korea’s National Health Insurance Service database. The sample was split into two groups based on vaccination status. The vaccinated sample was further split into booster and non-booster groups. Researchers tracked the patients for one year. The vaccinated group was tracked following vaccination. The results showed a statistically significant higher risk of cancer in the vaccinated group, including: Overall cancer: 27% higher risk Breast cancer: 20% higher risk Colorectal cancer: 28% higher risk Gastric cancer: 34% higher risk Lung cancer: 53% higher risk Prostate cancer: 69% higher risk Thyroid cancer: 35% higher risk
1:19

COVID vaccines linked to a 27% INCREASE in overall cancer risk, South Korean study finds. “There’s a one in a thousand chance that this result arose by chance,” Dr. John Campbell noted. Children’s Health Defense reports: The study used data from 2021-2023 for over 8.4 million people in South Korea’s National Health Insurance Service database. The sample was split into two groups based on vaccination status. The vaccinated sample was further split into booster and non-booster groups. Researchers tracked the patients for one year. The vaccinated group was tracked following vaccination. The results showed a statistically significant higher risk of cancer in the vaccinated group, including: Overall cancer: 27% higher risk Breast cancer: 20% higher risk Colorectal cancer: 28% higher risk Gastric cancer: 34% higher risk Lung cancer: 53% higher risk Prostate cancer: 69% higher risk Thyroid cancer: 35% higher risk

The Vigilant Fox 🦊

934,237 просмотров • 10 месяцев назад

Training robot foundation models faces two key hurdles: how to get enough data to train an effective model, and how to make sure that new skills can be acquired quickly. The team at Rhoda AI believes that the answer is training Direct Video Action models from web data. Web data is plentiful, to the point where Rhoda can train their base model on hundreds of years of video data. And then, with the addition of robot data, they can quickly adapt it to new tasks with as little as 20 hours of in-domain data, performing complex, multi-step manipulation tasks with their purpose-built video foundation model. Tongzhou Mu 🤖🦾🦿 Eric Chan and Changan Chen joined us to talk more about their approach. Watch Episode #79 of RoboPapers, with Michael Cho - Rbt/Acc, Chris Paxton, and Jiafei Duan, to learn more!
1:09:10

Training robot foundation models faces two key hurdles: how to get enough data to train an effective model, and how to make sure that new skills can be acquired quickly. The team at Rhoda AI believes that the answer is training Direct Video Action models from web data. Web data is plentiful, to the point where Rhoda can train their base model on hundreds of years of video data. And then, with the addition of robot data, they can quickly adapt it to new tasks with as little as 20 hours of in-domain data, performing complex, multi-step manipulation tasks with their purpose-built video foundation model. Tongzhou Mu 🤖🦾🦿 Eric Chan and Changan Chen joined us to talk more about their approach. Watch Episode #79 of RoboPapers, with Michael Cho - Rbt/Acc, Chris Paxton, and Jiafei Duan, to learn more!

RoboPapers

24,475 просмотров • 3 месяцев назад

This is the information Peter Hotez does not want to have to address. Years before the COVID catastrophe, a small contingent including RFK Jr., ICAN - Informed Consent Action Network CEO Del Bigtree, ICAN Lead Attorney, Aaron Siri, Esq., and others met with Tony Fauci, Francis Collins, and various heads of US health regulatory agencies to present a comprehensive assessment of vaccine safety and policy in the US, in front of representation from the Trump Administration. The presentation RFK Jr. delivered that day is known as the #VaccineSafetyProject and was developed in part by ICAN and vetted by countless professionals in their fields. The following video is the Vaccine Safety Project, as presented by Del Bigtree at the Truth About Cancer Conference in 2017. Watch intently, and find out more, then read what happened when ICAN engaged in this debate, on the record, with the Dept. of Health and Human Services: You have to see this to believe it. This is The Vaccine Safety Project, presented by ICAN CEO, Del Bigtree.
52:33

This is the information Peter Hotez does not want to have to address. Years before the COVID catastrophe, a small contingent including RFK Jr., ICAN - Informed Consent Action Network CEO Del Bigtree, ICAN Lead Attorney, Aaron Siri, Esq., and others met with Tony Fauci, Francis Collins, and various heads of US health regulatory agencies to present a comprehensive assessment of vaccine safety and policy in the US, in front of representation from the Trump Administration. The presentation RFK Jr. delivered that day is known as the #VaccineSafetyProject and was developed in part by ICAN and vetted by countless professionals in their fields. The following video is the Vaccine Safety Project, as presented by Del Bigtree at the Truth About Cancer Conference in 2017. Watch intently, and find out more, then read what happened when ICAN engaged in this debate, on the record, with the Dept. of Health and Human Services: You have to see this to believe it. This is The Vaccine Safety Project, presented by ICAN CEO, Del Bigtree.

The HighWire

758,331 просмотров • 3 лет назад

🚨 COVID-19 Vaccines: Should They Be Removed From the Market? Leading international physicians and scientists are calling for a global moratorium on mRNA vaccines after mounting evidence of harm. The data is in—heart damage, clotting, and long-term unknowns can no longer be ignored. It’s time to confront what public health agencies won’t. 👉 Help us fund independent medical research and protect patient safety worldwide. ➡️ Donate today: Credit: Presented by MWM (Menschliche Wissenschaft und Medizin), World Council for Health (WCH) North Group, and CSmedicus.org 📺 Watch the full international conference: #MedicalFreedom
0:50

🚨 COVID-19 Vaccines: Should They Be Removed From the Market? Leading international physicians and scientists are calling for a global moratorium on mRNA vaccines after mounting evidence of harm. The data is in—heart damage, clotting, and long-term unknowns can no longer be ignored. It’s time to confront what public health agencies won’t. 👉 Help us fund independent medical research and protect patient safety worldwide. ➡️ Donate today: Credit: Presented by MWM (Menschliche Wissenschaft und Medizin), World Council for Health (WCH) North Group, and CSmedicus.org 📺 Watch the full international conference: #MedicalFreedom

McCullough Foundation

32,660 просмотров • 10 месяцев назад

Today, we announced the launch of Zepto Atom - an advanced data insights subscription for Consumer Brands in India. The Zepto Atom subscription is a top-up to the already existing Zepto Brand Portal (which gives brands listed on the Zepto platform basic day-to-day data on their performance on Zepto and is available for free). The value of the Zepto Atom subscription is the next level of insights brands can derive from this tool, most of which are not available on any e-commerce platform in India today. For example: 1) PIN-code-by-PIN-code market share data and brand performance: Through Zepto Atom, brands can examine a live map of every neighbourhood and PIN code they have presence on Zepto and derive hyperlocal insights on their performance. For example, a brand can see on Zepto Atom Maps that their sales are under-indexed in the western neighbourhoods of Hyderabad and double down on pricing, marketing, or distribution efforts in those geographies to unlock growth. 2) Live metrics visibility refreshed every minute: On Zepto Atom, brands can see minute-by-minute sales, customer impressions, and conversion data and optimise advertising campaigns, pricing, and their product range according to different consumption trends for their products throughout the day and week. 3) Zepto GPT: Zepto Atom has an in-house Natural Language Processing (NLP) assistant that is trained on the Zepto Data set to give brands insights that can improve their performance. For example, brands can ask Zepto GPT "How can I grow my market share in Bengaluru for the protein bar category?" or "What are the key consumer preferences driving energy drink sales among Gen Z in Mumbai?". Zepto GPT then analyses the vast datasets within Zepto Atom to provide actionable answers, strategic recommendations, and even generates data reports on behalf of the brand. 4) Advanced Behavioural Data: Zepto Atom goes beyond basic sales and conversion data. We are now providing brands data on customer repeatability and retention, share of voice in search and home page, full-funnel visibility on customer purchase behaviour with their product etc. We will be doing a detailed webinar for all our partner brands this Friday at 3 PM to formally kick off onboarding to Zepto Atom. Looking forward to seeing you there!
1:44

Today, we announced the launch of Zepto Atom - an advanced data insights subscription for Consumer Brands in India. The Zepto Atom subscription is a top-up to the already existing Zepto Brand Portal (which gives brands listed on the Zepto platform basic day-to-day data on their performance on Zepto and is available for free). The value of the Zepto Atom subscription is the next level of insights brands can derive from this tool, most of which are not available on any e-commerce platform in India today. For example: 1) PIN-code-by-PIN-code market share data and brand performance: Through Zepto Atom, brands can examine a live map of every neighbourhood and PIN code they have presence on Zepto and derive hyperlocal insights on their performance. For example, a brand can see on Zepto Atom Maps that their sales are under-indexed in the western neighbourhoods of Hyderabad and double down on pricing, marketing, or distribution efforts in those geographies to unlock growth. 2) Live metrics visibility refreshed every minute: On Zepto Atom, brands can see minute-by-minute sales, customer impressions, and conversion data and optimise advertising campaigns, pricing, and their product range according to different consumption trends for their products throughout the day and week. 3) Zepto GPT: Zepto Atom has an in-house Natural Language Processing (NLP) assistant that is trained on the Zepto Data set to give brands insights that can improve their performance. For example, brands can ask Zepto GPT "How can I grow my market share in Bengaluru for the protein bar category?" or "What are the key consumer preferences driving energy drink sales among Gen Z in Mumbai?". Zepto GPT then analyses the vast datasets within Zepto Atom to provide actionable answers, strategic recommendations, and even generates data reports on behalf of the brand. 4) Advanced Behavioural Data: Zepto Atom goes beyond basic sales and conversion data. We are now providing brands data on customer repeatability and retention, share of voice in search and home page, full-funnel visibility on customer purchase behaviour with their product etc. We will be doing a detailed webinar for all our partner brands this Friday at 3 PM to formally kick off onboarding to Zepto Atom. Looking forward to seeing you there!

Aadit Palicha

712,239 просмотров • 1 год назад